Malignant Gastric Neoplasm — Trials

Malignant Gastric Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 652
Recruiting: 351
Ph III recruiting: 49
Growth YoY: +15.1%
Industry share: 26%
Top sponsor: Fudan University
Termination share: 26.2%
Trials / 1,000 deaths: 59.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (232)

clinicaltrialsPublishedShowing 1,051–1,056 of 1,056 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00192088	A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma	completed	Phase 2	43	Eli Lilly and CompanyINDUSTRY	1	Jan 26, 2007	clinicaltrials
NCT00209638	Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer	completed	Phase 1 / Phase 2	24	Hokkaido Gastrointestinal Cancer Study GroupOTHER	0	Apr 21, 2006	clinicaltrials